U.S. Medical Equipment Stock News

Carlisle Companies (CSL) has drawn fresh attention after reporting second quarter revenue and EBITDA above analyst expectations, alongside an employee stock option grant tied to its long term value creation plans. Despite the earnings beat, Carlisle Companies’ recent share price momentum has cooled. The stock is down about 10% on a 30‑day share price return and roughly 11% over 90 days, even though the 3‑year total shareholder return of about 29% and 5‑year total shareholder return of about...

Tutor Perini (TPC) is back in focus after reporting record operating cash flow of US$334.1 million for the first half of 2026, along with record quarterly revenue and a near record US$19.9b backlog. The share price tells a different part of the story. Tutor Perini’s stock has eased 6.6% over the past month after a strong run. However, the 90 day share price return of 9.9% and very large 3 year total shareholder return of roughly 10x point to momentum that has been building rather than...

AXT Inc. has seen its share price move sharply in recent years, and the question now is whether the current US$67.75 level can be explained by the revenue the business is generating. With AXT stock heavily in focus, the key issue is how much of that past share price run can be anchored to its sales rather than market excitement alone. AXT has delivered a roughly 28x three year share price return. This places a lot of weight on how much sales can support that kind of change in market...

Wolverine World Wide has seen its share price move in sharply different directions over recent years, which puts a spotlight on whether the current US$19.34 level lines up with the cash flows the business can produce. With investors weighing a mix of gains and setbacks, the question is how today’s valuation stacks up against what Wolverine World Wide’s cash generation can reasonably support. Over the past 3 years, Wolverine World Wide has delivered a total return of about 154%, which raises...

Alkermes (ALKS) has drawn fresh attention after appointing veteran biopharma executive Anne C. Whitaker to its board. The move expands the director group to eleven and adds extensive commercial and operational experience. Alkermes has had a strong run into 2026, with a year to date share price return of 65.29% and a 1 year total shareholder return of 63.61%. However, the 30 day share price return of 5.60% suggests some momentum has cooled, even as the board refresh signals that investors are...

MannKind’s new GLP-1 partnership puts inhaled weight-loss drug in focus MannKind (MNKD) is back in the spotlight after a worldwide licensing and collaboration deal with Rose Pharma to develop ROSE-010 Technosphere, an inhaled GLP-1 candidate for weight management. For investors watching MannKind, the Rose Pharma collaboration lands after a difficult stretch. The share price is down 36.1% year to date, and the 1-year total shareholder return has declined a similar 36.2%, despite a modest 0.9%...

Social Security is back in the headlines, and that puts senior-focused healthcare stocks under a brighter, harsher spotlight. Policy talk on benefit formulas, taxes and long term funding can ripple into how older Americans spend, save and seek care. For investors, that mix of risk and potential reward is hard to ignore. This article walks through three U.S. healthcare stocks tied to senior care and how they intersect with today’s debate. The stocks covered below are just a small sample from...

Copa Holdings (NYSE:CPA) reported preliminary August 2026 traffic figures, with both available seat miles and revenue passenger miles up 16.8% year over year, while the load factor held steady at 88.3%. Copa Holdings shares trade at US$131.05, with a 7.57% year-to-date share price gain and a 16.11% total shareholder return over one year, even though the 90-day share price return declined 13.23%. This suggests that longer-term momentum remains stronger than the recent pullback. Compare Copa...

SLM Corporation has delivered a powerful 3 year share price run, yet the stock has drifted lower over the past year, which puts fresh attention on whether its current price still lines up with the earnings behind it. For anyone considering SLM today, the key issue is how much of the past gains already reflect what the business earns. SLM has climbed 94.5% over the past 3 years, so a lot of the discussion now is about whether that move already bakes in what its profits can reasonably...

Fed rate hikes, stubborn inflation and expensive fuel are squeezing household budgets, which pushes more shoppers toward every discount, coupon and bulk offer they can find. That shift in behavior can help some value focused retailers while leaving others exposed to rising costs. This article examines how that tension plays out and highlights 3 stocks from the screener that appear positioned, for better or worse, in this environment. The three stocks below are just a starting sample. The full...

Exelixis has delivered a strong multi year share price run, and the question now is whether that move lines up with what the company earns today. With the stock recently closing at US$58.49, investors are increasingly asking if the earnings story is doing enough work to support that valuation. Over the past 5 years Exelixis has returned 185.3%, which puts real pressure on the current earnings base to justify where the stock now trades. The recent US FDA review extension for cancer drug...

NVIDIA (NasdaqGS:NVDA) is promoting a "neocloud" model that leans on regional cloud and AI partners rather than only hyperscalers. Recent comments from CEO Jensen Huang outline plans to help finance and coordinate AI data center projects spanning manufacturing, power and infrastructure providers. External industry analysis describes NVIDIA as an emerging "bank of AI" as it arranges capital and partnerships across its wider ecosystem. NVIDIA's push into neocloud infrastructure and AI...

Extreme Networks (EXTR) is putting its agentic AI ambitions into production with the general availability of Extreme Agent ONE Coworker, a subscription add-on now live for Platform ONE customers worldwide. Recent trading has been choppy for Extreme Networks, with the share price up 1.92% over the last day and 5.34% across the past week, yet down 28.90% on a 90 day share price basis and slightly negative on a 1 year total shareholder return. This comes even after a 129.76% total shareholder...

Mercury Systems recently extended Chairman and CEO Bill Ballhaus's employment contract by three years through August 15, 2030, and reaffirmed the financial guidance it issued on its August 2026 earnings call. The move ties leadership continuity directly to the current operating playbook. This signals that Mercury Systems aims to keep execution, backlog quality, and margin mix on the same trajectory that underpinned its recent operational and financial results. We will look at how Mercury...

Amgen reported that the FDA approved a significant update to IMDELLTRA's U.S. prescribing information, reducing the recommended monitoring after the first two infusions to 6 to 8 hours from roughly a full day, while keeping later cycle guidance and safety precautions intact. The shorter monitoring window directly affects real world treatment logistics by potentially easing capacity constraints for community oncology clinics, where most U.S. cancer patients receive care, and lowering...

Recent Price Moves And Business Context For ZTO Express (Cayman) ZTO Express (Cayman) (ZTO) recently closed at US$20.86, with the share price down about 10% over the past month and roughly 5% over the past 3 months. Over the past year the stock has delivered a total return of about 15%. Longer lookback periods such as 3 and 5 years show weaker compounded results for investors who held through that stretch. The logistics provider reports annual revenue of CN¥54,207.651 and net income of...

Reddit has delivered rapid revenue growth and upbeat earnings news, yet the share price is still down sharply over the past year. That mix of strong recent headlines and a weaker stock chart raises a simple question for investors who follow Reddit stock: whether today's market value lines up with what the company currently earns. The share price has fallen 43.5% over the past year, which puts the focus squarely on whether Reddit's earnings profile can support the valuation that...

Lennar stock inched 1.7% higher to about $79.70 after earnings, a muted move for a builder juggling thinner profitability and a rich valuation tag. The headline is not the delivery count or order pace. The real story is that quarterly net margin sat at 6.6% while the trailing twelve month profit margin sat at 4%, and the market is still paying a P/E of 14.9x, above industry and peer averages. Investors are rewarding the homebuilder for execution, yet the price reaction suggests many are...

Advanced Micro Devices (NasdaqGS:AMD) and SiFive are working together to optimize AMD's ROCm software for RISC-V datacenter servers. The project focuses on SiFive's RISC-V powered datacenter development platform, targeting AI acceleration workloads in cloud and enterprise environments. The collaboration extends AMD's AI software stack beyond x86 CPUs into the open standard RISC-V ecosystem used in heterogeneous computing setups. AMD and SiFive moving ROCm onto RISC-V datacenter hardware fits...

ATI Inc. recently presented at Morgan Stanley's 14th Annual Laguna Conference, outlining aerospace and defense demand trends, record backlog levels, and higher 2026 adjusted EBITDA and free cash flow guidance. The updated outlook for high teens defense growth and a strong order book gives investors more detail on how ATI’s materials portfolio is tied to long-cycle aerospace and military programs. Next, the focus turns to how ATI’s raised guidance and record backlog reshape the existing...

IQVIA Holdings recently priced a US$2.0b senior notes offering due 2034 at a 6.375% coupon, with proceeds earmarked to redeem 5.000% notes due 2026, partly repay its revolving credit facility, and cover transaction costs. The launch of IQVIA Predictive Clinical Development, which targets materially faster trial startup, enrollment and data cleaning, underlines how IQVIA is weaving AI into core clinical workflows rather than treating it as a side product. The next area of focus will be how...

F5 (NasdaqGS:FFIV) announced a new partnership with Omnissa to deliver secure, high-performance digital workspaces for enterprises. The collaboration combines F5 application delivery and Zero Trust security with Omnissa digital workspace tools for hybrid and virtual desktop setups. F5 introduced new device intelligence and agentic AI detection features for its Distributed Cloud Bot Defense to counter automated account abuse. The Omnissa workspace partnership and upgraded Bot Defense tools...

ON Semiconductor (ON) is back in focus after unveiling its Embedded Power Platform and confirming a technology engagement with Subaru. Both moves link the stock directly to AI data centers and future electrified vehicles. Recent trading tells a story of enthusiasm colliding with caution. ON Semiconductor’s share price has fallen about 44% over the past 90 days and is down 14% on a 30 day view, even though the year to date share price return is 20.46% and the 1 year total shareholder return is...

Coeur Mining (CDE) moved back into focus after a roughly 10% pullback from its late August high, prompting fresh questions about whether the stock’s recent slide has opened a new entry window. That pullback comes after a strong run for Coeur Mining, with the share price showing a 14.11% 90 day share price return and a 13.85% year to date share price return. Total shareholder return over three and five years has been very large, suggesting momentum has been building over time despite shorter...